873222-16-3

Basic information

• Product Name: 2-Oxazolidinone, 4-[(1E)-2-(4-octylphenyl)ethenyl]-, (4R)-
• CAS NO: 873222-16-3
• Molecular Formula: C19H27NO2
• Molecular Weight: 301.429
• Mol File: 873222-16-3.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 2-Oxazolidinone, 4-[(1E)-2-(4-octylphenyl)ethenyl]-, (4R)-(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Oxazolidinone, 4-[(1E)-2-(4-octylphenyl)ethenyl]-, (4R)-(873222-16-3)
• EPA Substance Registry System: 2-Oxazolidinone, 4-[(1E)-2-(4-octylphenyl)ethenyl]-, (4R)-(873222-16-3)

Safety Data

• Hazardous Substances Data: 873222-16-3(Hazardous Substances Data)

Upstream product

• 132682-21-4 (S)-(+)-4-(2-oxazolidonyl)-methyltriphenylphosphonyl iodide 
• 49763-66-8 4-octylbenzaldehyde 

Relevant articles and documents

SPHINGOLIPID DERIVATIVES AND THE COMPOSITION FOR ANTI-CANCER CONTAINING THE SAME

Disclosed are a novel sphingolipid derivative having a sphingosine kinase suppressing activity and a composition containing the same. When the newly synthesized sphingolipid derivative of the invention is used, it is possible to maintain concentrations of ceramide and sphingosine to be high by preventing ceramide and sphingosine from being phosphorylated due to sphingosine kinase since an activity of sphingosine kinase is suppressed. In addition, since the apoptosis is induced in a cancer cell by ceramide and sphingosine, it is possible to treat or prevent a cancer or disease related to the cancer. Further, it is possible to treat or prevent a hyper- proliferative disease such as cancer or proliferation-promoting activity of sphingosine kinase. Accordingly, the composition containing the same can be used as a composition for suppressing sphingosine kinase and a composition for treating or preventing a cancer or hyper-proliferative disease.